130 related articles for article (PubMed ID: 34881462)
1. Efficacy of a combination of paclitaxel and radiation therapy against cutaneous angiosarcoma: A single-institution retrospective study of 21 cases.
Seo T; Kitamura S; Yanagi T; Ujiie H
J Dermatol; 2022 Mar; 49(3):383-386. PubMed ID: 34881462
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.
Yonekura S; Endo Y; Fujii H; Ishikawa M; Egawa G; Kabashima K
J Dermatol; 2023 Nov; 50(11):1493-1496. PubMed ID: 37400887
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study.
Fujisawa Y; Yoshino K; Kadono T; Miyagawa T; Nakamura Y; Fujimoto M
Br J Dermatol; 2014 Dec; 171(6):1493-500. PubMed ID: 24814962
[TBL] [Abstract][Full Text] [Related]
4. Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases.
Fujimura T; Maekawa T; Kato H; Ito T; Matsushita S; Yoshino K; Fujisawa Y; Ishizuki S; Segawa K; Yamamoto J; Hashimoto A; Kambayashi Y; Asano Y
J Dermatol; 2023 Jul; 50(7):912-916. PubMed ID: 36938650
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol.
Fujimura T; Yoshino K; Nakamura M; Kato H; Ito T; Maekawa T; Fujisawa Y; Matsushita S; Amagai R; Yamazaki E; Takahashi M; Tamabuchi E; Hashimoto A; Kambayashi Y; Yamazaki N; Miyata T; Asano Y
Exp Dermatol; 2024 Jan; 33(1):e14976. PubMed ID: 37946551
[TBL] [Abstract][Full Text] [Related]
6. Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience.
Fujisawa Y; Nakamura Y; Kawachi Y; Otsuka F
J Dermatolog Treat; 2014 Oct; 25(5):419-23. PubMed ID: 23210914
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.
Kajihara I; Kanemaru H; Miyake T; Aoi J; Masuguchi S; Fukushima S; Jinnin M; Ihn H
Drug Discov Ther; 2015 Feb; 9(1):75-7. PubMed ID: 25788055
[TBL] [Abstract][Full Text] [Related]
8. The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.
Chen TW; Pang A; Puhaindran ME; Maw MM; Loong HH; Sriuranpong V; Chang CC; Mingmalairak S; Hirose T; Endo M; Kawai A; Farid M; Tan SH; Goh WL; Quek R; Chan JCH; Leung AKC; Ngan RKC
Cancer Sci; 2021 Mar; 112(3):1095-1104. PubMed ID: 33393133
[TBL] [Abstract][Full Text] [Related]
9. Pazopanib treatment slows progression and stabilizes disease in patients with taxane-resistant cutaneous angiosarcoma.
Ogata D; Yanagisawa H; Suzuki K; Oashi K; Yamazaki N; Tsuchida T
Med Oncol; 2016 Oct; 33(10):116. PubMed ID: 27613162
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multicentre prospective observational study.
Fujisawa Y; Fujimura T; Matsushita S; Yamamoto Y; Uchi H; Otsuka A; Funakoshi T; Miyagi T; Hata H; Gosho M; Kambayashi Y; Aoki M; Yanagi T; Ohira A; Nakamura Y; Maeda T; Yoshino K
Br J Dermatol; 2020 Nov; 183(5):831-839. PubMed ID: 32198756
[TBL] [Abstract][Full Text] [Related]
11. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.
Fury MG; Antonescu CR; Van Zee KJ; Brennan MF; Maki RG
Cancer J; 2005; 11(3):241-7. PubMed ID: 16053668
[TBL] [Abstract][Full Text] [Related]
12. Angiosarcoma of the face and scalp: effective systemic treatment in the older patient.
Letsa I; Benson C; Al-Muderis O; Judson I
J Geriatr Oncol; 2014 Jul; 5(3):276-80. PubMed ID: 24685486
[TBL] [Abstract][Full Text] [Related]
13. [Single-center study of different treatment for advanced or unresectable angiosarcoma patients].
Peng RQ; Xu BS; Liu YY; Yang QQ; Pan QZ; Zhang X
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):74-81. PubMed ID: 36709123
[No Abstract] [Full Text] [Related]
14. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
Oashi K; Shibata T; Namikawa K; Takahashi A; Yokota K; Nakano E; Teramoto Y; Tsutsumida A; Maeda T; Yamazaki N;
BMC Cancer; 2020 Jul; 20(1):652. PubMed ID: 32660439
[TBL] [Abstract][Full Text] [Related]
15. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
Italiano A; Cioffi A; Penel N; Levra MG; Delcambre C; Kalbacher E; Chevreau C; Bertucci F; Isambert N; Blay JY; Bui B; Antonescu C; D'Adamo DR; Maki RG; Keohan ML
Cancer; 2012 Jul; 118(13):3330-6. PubMed ID: 22045619
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial.
Ray-Coquard IL; Domont J; Tresch-Bruneel E; Bompas E; Cassier PA; Mir O; Piperno-Neumann S; Italiano A; Chevreau C; Cupissol D; Bertucci F; Bay JO; Collard O; Saada-Bouzid E; Isambert N; Delcambre C; Clisant S; Le Cesne A; Blay JY; Penel N
J Clin Oncol; 2015 Sep; 33(25):2797-802. PubMed ID: 26215950
[TBL] [Abstract][Full Text] [Related]
17. Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment.
Park C; Kim M; Kwak Y; Moon KC; Kim SH; Keam B; Kim YJ; Kim TM; Kim DW
Cancer Res Treat; 2021 Oct; 53(4):1195-1203. PubMed ID: 33540493
[TBL] [Abstract][Full Text] [Related]
18. Management of Cutaneous Angiosarcoma: an Update Review.
Bi S; Zhong A; Yin X; Li J; Cen Y; Chen J
Curr Treat Options Oncol; 2022 Feb; 23(2):137-154. PubMed ID: 35182299
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
[TBL] [Abstract][Full Text] [Related]
20. Angiosarcomas and taxanes.
Penel N; Lansiaux A; Adenis A
Curr Treat Options Oncol; 2007 Dec; 8(6):428-34. PubMed ID: 18066504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
